Quantcast
Last updated on April 23, 2014 at 13:55 EDT

Latest Prosensa Stories

2013-04-22 12:30:56

Conference to include data from Sarepta, GSK/Prosensa on exon-skipping trials for Duchenne dystrophy, plus updates on many other potential therapies TUCSON, Ariz., April 22, 2013 /PRNewswire-USNewswire/ -- Some 500 members of the scientific and medical research community are scheduled to attend the 2013 MDA Scientific Conference, "Therapy Development for Neuromuscular Diseases: Translating Hope into Promise," April 21-24 in Washington, D.C., according to representatives of the Muscular...

2008-10-14 06:00:36

The Foundation to Eradicate Duchenne (FED), the CureDuchenne Foundation, AVI BioPharma and Prosensa will host an Exon Skipping Conference for Duchenne Muscular Dystrophy from October 14 -17, 2008 at the Banbury Center of Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. Participants are being drawn from a wide area of research, from chemistry to regulatory authorities, to critically review progress on oligonucleotides as therapeutic agents for Duchenne Muscular Dystrophy. Over the...